Search

Your search keyword '"Sporotrichosis immunology"' showing total 153 results

Search Constraints

Start Over You searched for: Descriptor "Sporotrichosis immunology" Remove constraint Descriptor: "Sporotrichosis immunology"
153 results on '"Sporotrichosis immunology"'

Search Results

1. Antibody Isotype and Subclass Responses in Human Patients With Different Clinical Presentations of Sporotrichosis.

3. Human serum proteins bind to Sporothrix schenckii conidia with differential effects on phagocytosis.

4. Sporothrix globosa melanin inhibits antigenpresentation by macrophages and enhances deep organ dissemination.

5. CD4 + T cells apoptosis and conversion of Th1/Th2-type cytokines promote the progress of sporotrichosis.

6. Th2 Biased Immunity With Altered B Cell Profiles in Circulation of Patients With Sporotrichosis Caused by Sporothrix globosa .

7. Tregs in the immune response of BALB/c mice experimentally infected with species of the Sporothrix genus.

8. Transient Foxp3(+) regulatory T-cell depletion enhances protective Th1/Th17 immune response in murine sporotrichosis caused by Sporothrix schenckii.

9. Imbalance of Th1, Th17, and Treg cells in peripheral blood of patients with lymphocutaneous sporotrichosis: a comparative study.

10. Systemic sporotrichosis in an alcoholic patient.

11. Proteomic analysis of Sporothrix schenckii cell wall reveals proteins involved in oxidative stress response induced by menadione.

12. Skin Mast Cells Contribute to Sporothrix schenckii Infection.

13. Prophylactic and therapeutic vaccines against sporotrichosis. Feasibility and prospects.

14. Immunization with recombinant enolase of Sporothrix spp. (rSsEno) confers effective protection against sporotrichosis in mice.

15. Disseminated Sporotrichosis in a Liver Transplant Patient: A Case Report.

16. The importance of Toll-like receptor 4 during experimental Sporothrix brasiliensis infection.

17. Analysis of some immunogenic properties of the recombinant Sporothrix schenckii Gp70 expressed in Escherichia coli.

18. The impact of the absence of Toll-like receptor-2 during Sporothrix brasiliensis infection.

19. Natural killer cells are pivotal for in vivo protection following systemic infection by Sporothrix schenckii.

20. Co-infection with feline retrovirus is related to changes in immunological parameters of cats with sporotrichosis.

22. Experimental sporotrichosis in a cyclophosphamide-induced immunosuppressed mice model.

23. Clinical features, fungal load, coinfections, histological skin changes, and itraconazole treatment response of cats with sporotrichosis caused by Sporothrix brasiliensis.

24. Sporotrichosis between 1898 and 2017: The evolution of knowledge on a changeable disease and on emerging etiological agents.

25. An immunoproteomic approach revealing peptides from Sporothrix brasiliensis that induce a cellular immune response in subcutaneous sporotrichosis.

26. Dectin-1 expression by macrophages and related antifungal mechanisms in a murine model of Sporothrix schenckii sensu stricto systemic infection.

27. Exploring virulence and immunogenicity in the emerging pathogen Sporothrix brasiliensis.

28. Comparative efficacy and toxicity of two vaccine candidates against Sporothrix schenckii using either Montanide™ Pet Gel A or aluminum hydroxide adjuvants in mice.

29. The NLRP3 inflammasome contributes to host protection during Sporothrix schenckii infection.

30. Anti-inflammatory activity of Vismia guianensis (Aubl.) Pers. extracts and antifungal activity against Sporothrix schenckii.

31. [Presence of lactoferrin (LF) in lymphocutaneous sporotrichosis. Yeast-bound antimicrobial peptide].

32. Is There Any Difference between the In Situ and Systemic IL-10 and IFN-γ Production when Clinical Forms of Cutaneous Sporotrichosis Are Compared?

33. Molecular Components of the Sporothrix schenckii Complex that Induce Immune Response.

34. Disseminated cutaneous sporotrichosis associated with ocular lesion in an immunocompetent patient.

35. Lower percentage of CD8+ T cells in peripheral blood of patients with sporotrichosis.

37. Antifungal curcumin promotes chitin accumulation associated with decreased virulence of Sporothrix schenckii.

38. Response of Cytokines and Hydrogen Peroxide to Sporothrix schenckii Exoantigen in Systemic Experimental Infection.

39. A cell wall protein-based vaccine candidate induce protective immune response against Sporothrix schenckii infection.

40. Immune Response Induced by an Immunodominant 60 kDa Glycoprotein of the Cell Wall of Sporothrix schenckii in Two Mice Strains with Experimental Sporotrichosis.

41. Proteomics-Based Characterization of the Humoral Immune Response in Sporotrichosis: Toward Discovery of Potential Diagnostic and Vaccine Antigens.

42. Optimal clearance of Sporothrix schenckii requires an intact Th17 response in a mouse model of systemic infection.

43. Bone involvement by Sporothrix schenckii in an immunocompetent child.

44. [Serological diagnosis of sporotrichosis using an antigen of Sporothrix schenckii sensu stricto mycelium].

45. Immunoproteomic analysis reveals a convergent humoral response signature in the Sporothrix schenckii complex.

46. Involvement of major components from Sporothrix schenckii cell wall in the caspase-1 activation, nitric oxide and cytokines production during experimental sporotrichosis.

47. Recombinant murine IL-12 promotes a protective Th1/cellular response in Mongolian gerbils infected with Sporothrix schenckii.

48. Immune reconstitution inflammatory syndrome in HIV and sporotrichosis coinfection: report of two cases and review of the literature.

49. Mouse bone marrow-derived dendritic cells can phagocytize the Sporothrix schenckii, and mature and activate the immune response by secreting interleukin-12 and presenting antigens to T lymphocytes.

50. The immune response against Candida spp. and Sporothrix schenckii.

Catalog

Books, media, physical & digital resources